Peering Into Regeneron Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NYSE:REGN) has seen a 10.17% increase in its short percent of float, now at 1.95% of all regular shares available for trading. This indicates a rise in bearish sentiment among investors. However, compared to its peers, Regeneron's short interest is still lower than the average of 6.90%.
July 19, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals has experienced a 10.17% increase in short interest, now at 1.95% of its float. This suggests a rise in bearish sentiment, although its short interest remains lower than the peer average of 6.90%.
The increase in short interest indicates a rise in bearish sentiment among investors, which could put downward pressure on the stock price in the short term. However, the short interest is still lower than the peer average, which may mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100